Please use this identifier to cite or link to this item: http://gukir.inflibnet.ac.in:8080/jspui/handle/123456789/3968
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAshajyothi C
dc.contributor.authorPrabhurajeshwar C
dc.contributor.authorHandral H.K
dc.contributor.authorKelmani C.R.
dc.date.accessioned2020-06-12T15:02:06Z-
dc.date.available2020-06-12T15:02:06Z-
dc.date.issued2016
dc.identifier.citationEnvironmental Nanotechnology, Monitoring and Management , Vol. 5 , , p. 81 - 87en_US
dc.identifier.uri10.1016/j.enmm.2016.04.002
dc.identifier.urihttp://gukir.inflibnet.ac.in:8080/jspui/handle/123456789/3968-
dc.description.abstractGreen chemistry approaches for synthesizing biogenic nanoparticles brings nanotechnology and microbial biotechnology towards the developments in the nano-biotechnology. Nano-biotechnology is extending diverse applications in bio-medical studies especially in the field of biosensors, electrochemical sensors, medicine, healthcare and agriculture. In this study, we aim to evaluate antifungal and anti-mycelium activities of biogenic Silver (Ag), Copper (Cu), Zinc oxide (ZnO) and Gold (Au) nanoparticles (NPs) against pathogenic fungi. Selected nanoparticles except Gold have shown acceptable susceptibility towards fungi including C. albicans MTCC 3017 and C. neoformans MTCC 1347. In all treatments, Amphotericin B (AMB) and Fluconazole antifungal drugs were considered as "gold standards". Minimum inhibitory concentration of AgNPs, CuNPs as well as ZnONPs for non-spore forming fungi (C. albicans MTCC 3017 and C. neoformans MTCC 1347) were recorded at ? = 8 ?g/ml and for spore forming fungi (A. niger MTCC 282 and F. oxysporum MTCC 284) at ?16 ?g/ml. Further, anti-mycelium studies were carried using standard amended nutrient agar method. Anti-mycelium effect of biogenic NPs was recorded towards A. niger MTCC 282 and F. oxysporum MTCC 284, showing the highest effect by AgNPs (72.8%) as compared to Cu, ZnONPs and standard antifungal drug. Thus, highlighting the biogenic nanoparticles as an alternative source for assessing antifungal and anti-mycelium activities. © 2016 Elsevier B.V. All rights reserved.en_US
dc.publisherElsevier B.V.
dc.subjectAmphotericin B
dc.subjectAnti-mycelium activity
dc.subjectAntifungal activity
dc.subjectBiogenic nanoparticles
dc.subjectMinimum inhibitory concentration
dc.titleInvestigation of antifungal and anti-mycelium activities using biogenic nanoparticles: An eco-friendly approachen_US
dc.typeArticle
Appears in Collections:1. Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.